6:21 PM
 | 
Aug 11, 2014
 |  BC Extra  |  Financial News

Ligand planning $225M note deal, launches $200M buyback

Ligand Pharmaceuticals Inc. (NASDAQ:LGND) said late Monday it plans to raise $225 million through the sale of convertible senior notes due in 2019. Additionally, the company said its board has authorized a one-year $200 million...

Read the full 157 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >